American College of Clinical Pharmacy
      Search      Cart

Women's Health PRN Focus Session -- Pharmacotherapeutic Updates in Women’s Health: Focus on Human Papillomavirus, Female Sexual Dysfunction, and Menopause

Tuesday, October 29, 2019 from 3:00 PM to 4:30 PM EST at 3rd Floor: Trianon Ballroom

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-19-184-L01-P
Activity Type: An Application-Based Activity

  • Moderator: Lauren Leader, Pharm.D., BCPS

Public “Cervix” Message: Updates in Human Papillomavirus (HPV)
3:00 PM

  • Speaker: Macary Weck Marciniak, Macary Weck Marciniak, Pharm.D., BCPS, FAPhA
    Clinical Associate Professor, University of North Carolina, Chapel Hill, North Carolina

Learning Objectives
1. Evaluate existing clinical recommendations data regarding long term efficacy regarding the use of the HPV vaccine.
2. Identify implications of vaccine administration age expansion.
3. Discuss emerging long term efficacy and safety data of the HPV vaccine.
4. Identify the pharmacist’s role and potential barriers to increasing community administration of the vaccine.
The Little Pink Pill: Updates in Female Sexual Dysfunction
3:30 PM

  • Sarah M. Westberg, Pharm.D., BCPSSpeaker: Sarah M. Westberg, Pharm.D., BCPS
    Co-Associate Dean of Clinical Affairs and Professor, University of Minnesota College of Pharmacy, Minneapolis, Minnesota
      View Biography

Learning Objectives
1. Analyze current US FDA approved therapies (Flibanserin) in the management of female sexual dysfunction (FSD).
2. Discuss and novel uses of existing therapies utilized to treat FSD.
3. Identify future medication therapies currently in development for management of FSD.
Hot Flash News Flash: Updates in Menopause
4:00 PM

  • Veronica  Vernon, Veronica Vernon, Pharm.D., BCPS, BCACPSpeaker: Veronica Vernon, Veronica Vernon, Pharm.D., BCPS, BCACP
    Assistant Professor of Pharmacy Practice, Butler University College of Pharmacy and Health Sciences
      View Biography

Learning Objectives
1. Interpret data regarding available pharmacotherapeutic options, for vasomotor and urogenital symptoms of menopause.
2. Discuss emerging medication therapies, including efficacy and safety data, for the management of menopausal symptoms.
3. Identify the pharmacist’s role in menopausal counseling.